BridgeMD
New treatment option for Thyroid
Official title A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
ClinicalTrials.gov ID: NCT06800482
What this study is testing
- What it's testing
- The randomized, actively controlled, non-inferiority trial is scheduled to begin in August 2024 and run through August 2026. Inclusion criteria: (1) has undergone microwave ablation of thyroid or thyroidectomy (including endoscopy and opening) at the Department of Thyroid Surgery of West China Hospital of Sichuan University, (2) is between 18 and 90 years old, (3) speaks Chinese, (4) has the email address and operational ability required to complete the visit, (5) does not have a mental illness or take psychotropic drugs, (6) Voluntarily participate in clinical trials and sign informed consent.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- clinical diagnosis of papillary thyroid cancer
- has underwent thyroid surgery (including endoscopic and open thyroid surgery)
- 18 to 90 years of age
- spoke Chinese
- has the ability to use mobile phones and the Internet to complete the visit
You likely can't join if
- postoperative hospital stay more than 5 days
- inability to complete an online visit (no access to the device or the Internet
- high risk of postoperative complications (recurrent laryngeal nerve injury, etc.)
- unable to participate due to comorbidities, laboratory test results or physical disability
- pregnancy
- has mental illness or take psychotropic drugs, and were not able to perform the surgery
See the full eligibility criteria
- clinical diagnosis of papillary thyroid cancer
- has underwent thyroid surgery (including endoscopic and open thyroid surgery)
- 18 to 90 years of age
- spoke Chinese
- has the ability to use mobile phones and the Internet to complete the visit
- voluntarily participate in clinical trials and sign informed consent.
- postoperative hospital stay more than 5 days
- inability to complete an online visit (no access to the device or the Internet
- high risk of postoperative complications (recurrent laryngeal nerve injury, etc.)
- unable to participate due to comorbidities, laboratory test results or physical disability
- pregnancy
- has mental illness or take psychotropic drugs, and were not able to perform the surgery
The study team makes the final eligibility decision.
Where it's taking place
- Chengdu, Sichuan, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chengdu, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.